Human promyelocytic leukemia (HL-60) cells with high expression of β2 integrins, LFA-1, and Mac-1 were used to construct CMNVs, which exhibited superior targeting to inflammatory brain microvascular endothelial cells [84]. Here, ITGB2 is linked to acute promyelocytic leukemia.